RINTEZEX Canadian Trademark Information

Pharmaceutical preparations for the treatment of disorders of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases, ocular motility disorders; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood, anxiety and cognitive disorders, migraines and pain; pharmaceutical preparations for the treatment of immunologic diseases, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the treatment of disorders of the cardio-vascular system; pharmaceutical preparations for the treatment of respiratory diseases; pharmaceutical preparations for the treatment of musculo-skeletal disorders, namely connective tissue diseases, bone diseases, spinal diseases back pain, fractures, sprains and cartilage injuries; anti-inflammatories; pharmaceutical preparations for use in dermatology, namely preparations for the treatment of dermatitis, skin pigmentation diseases and the repair of tissue and skin; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the use of ophthalmology.Pharmaceutical prepara...

Perfect for these industries

Pharmaceutical Products

Words that describe this mark

pharmaceutical preparations treatment disorders central nervous central nervous infections brain diseases central nervous movement disorders spinal cord diseases ocular motility disorders pharmaceutical preparations treatment psychiatric diseases mood anxiety cognitive

Abandonment Notice! On Wednesday, June 25, 2014, status on the RINTEZEX trademark changed to Interruption of proceeding. Apply Now for this name starting at $449!

CAUTION: Although Canada registration for this particular filing is inactive, the mark may still enjoy common law rights, or may have been applied for again in a separate application. Further research may be warranted to determine where this mark is truly abandoned in commerce.

On Tuesday, December 2, 2008, a canadian trademark registration was filed for RINTEZEX by Novartis AG *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 1420339. The current status of this trademark filing is Interruption of proceeding. The RINTEZEX trademark is filed in the description of Pharmaceutical preparations for the treatment of disorders of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases, ocular motility disorders; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood, anxiety and cognitive disorders, migraines and pain; pharmaceutical preparations for the treatment of immunologic diseases, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the treatment of disorders of the cardio-vascular system; pharmaceutical preparations for the treatment of respiratory diseases; pharmaceutical preparations for the treatment of musculo-skeletal disorders, namely connective tissue diseases, bone diseases, spinal diseases back pain, fractures, sprains and cartilage injuries; anti-inflammatories; pharmaceutical preparations for use in dermatology, namely preparations for the treatment of dermatitis, skin pigmentation diseases and the repair of tissue and skin; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the use of ophthalmology. , Pharmaceutical preparations for the treatment of disorders of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases, ocular motility disorders; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood, anxiety and cognitive disorders, migraines and pain; pharmaceutical preparations for the treatment of immunologic diseases, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the treatment of disorders of the cardio-vascular system; pharmaceutical preparations for the treatment of respiratory diseases; pharmaceutical preparations for the treatment of musculo-skeletal disorders, namely connective tissue diseases, bone diseases, spinal diseases back pain, fractures, sprains and cartilage injuries; anti-inflammatories; pharmaceutical preparations for use in dermatology, namely preparations for the treatment of dermatitis, skin pigmentation diseases and the repair of tissue and skin; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the use of ophthalmology. , Pharmaceutical preparations for the treatment of disorders of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases, ocular motility disorders; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood, anxiety and cognitive disorders, migraines and pain; pharmaceutical preparations for the treatment of immunologic diseases, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the treatment of disorders of the cardio-vascular system; pharmaceutical preparations for the treatment of respiratory diseases; pharmaceutical preparations for the treatment of musculo-skeletal disorders, namely connective tissue diseases, bone diseases, spinal diseases back pain, fractures, sprains and cartilage injuries; anti-inflammatories; pharmaceutical preparations for use in dermatology, namely preparations for the treatment of dermatitis, skin pigmentation diseases and the repair of tissue and skin; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the use of ophthalmology. .

Get FREE email alerts

100% Satisfaction Guarantee

protect your valuable brand now.

Classification Information

Class Code:	005 - Pharmaceutical Products
Description:	Pharmaceuticals and herbicides

Matter History Events

Status Date	Record Status Description
2014-06-25	Interruption of proceeding - Abandoned - Subsection 40(3)
2013-12-02	National prosecution history entry - Extension of Time
2013-06-03	National prosecution history entry - Extension of Time
2012-12-03	National prosecution history entry - Extension of Time
2012-06-04	National prosecution history entry - Extension of Time
2011-11-10	National prosecution history entry - Extension of Time
2009-10-16	National prosecution history entry - Allowed
2009-10-16	National prosecution history entry - Allowance Notice Sent
2009-07-01	Application published - Advertised
2009-06-25	Application accepted - Approved
2009-05-04	National prosecution history entry - Approval Notice Sent
2009-04-14	National prosecution history entry - Search Recorded
2009-04-14	National prosecution history entry - Examiner's First Report
2008-12-08	Filing date accorded - Formalized
2008-12-03	National prosecution history entry - Created
2008-12-02	Application filed - Filed

Word Mark:	RINTEZEX
Current Status:	Interruption of proceeding DEAD Mark! Start a New Filing Request 6/25/2014
Application Number:	1420339
Filing Date:	Tuesday, December 2, 2008
Filing Place:	Canada
Registration Date:	Not Available
Register Type:	Primary
Type Of Mark:	Trademark
Mark Feature:	Word
Use In Commerce:	No
Publication Registration:	Wednesday, July 1, 2009
Opposition:	7/1/2009 - 7/1/2009
Last Applicant/Owner:	NOVARTIS AG ******* ****** * **
Correspondent:	Not provided

Goods and Services Information
Description:	(1) - Pharmaceutical preparations for the treatment of disorders of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases, ocular motility disorders; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood, anxiety and cognitive disorders, migraines and pain; pharmaceutical preparations for the treatment of immunologic diseases, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the treatment of disorders of the cardio-vascular system; pharmaceutical preparations for the treatment of respiratory diseases; pharmaceutical preparations for the treatment of musculo-skeletal disorders, namely connective tissue diseases, bone diseases, spinal diseases back pain, fractures, sprains and cartilage injuries; anti-inflammatories; pharmaceutical preparations for use in dermatology, namely preparations for the treatment of dermatitis, skin pigmentation diseases and the repair of tissue and skin; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the use of ophthalmology. (2) - Pharmaceutical preparations for the treatment of disorders of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases, ocular motility disorders; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood, anxiety and cognitive disorders, migraines and pain; pharmaceutical preparations for the treatment of immunologic diseases, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the treatment of disorders of the cardio-vascular system; pharmaceutical preparations for the treatment of respiratory diseases; pharmaceutical preparations for the treatment of musculo-skeletal disorders, namely connective tissue diseases, bone diseases, spinal diseases back pain, fractures, sprains and cartilage injuries; anti-inflammatories; pharmaceutical preparations for use in dermatology, namely preparations for the treatment of dermatitis, skin pigmentation diseases and the repair of tissue and skin; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the use of ophthalmology. (3) - Pharmaceutical preparations for the treatment of disorders of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases, ocular motility disorders; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood, anxiety and cognitive disorders, migraines and pain; pharmaceutical preparations for the treatment of immunologic diseases, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the treatment of disorders of the cardio-vascular system; pharmaceutical preparations for the treatment of respiratory diseases; pharmaceutical preparations for the treatment of musculo-skeletal disorders, namely connective tissue diseases, bone diseases, spinal diseases back pain, fractures, sprains and cartilage injuries; anti-inflammatories; pharmaceutical preparations for use in dermatology, namely preparations for the treatment of dermatitis, skin pigmentation diseases and the repair of tissue and skin; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the use of ophthalmology.

Perfect for these industries

Words that describe this mark

a canadian trademark registration was filed for by . The Canadian IP office has given the trademark application number of . The current status of this trademark filing is . The correspondent listed for is The trademark is filed in the description of .

Trademarkia is the largest search engine for U.S., China, European Union, Canada, and Australia Trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia network law firms! You can register your trademark in 180+ countries in the world through Trademarkia Network. Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

100% Satisfaction Guarantee

protect your valuable brand now.

How it works

1. Trademarkia Network Law firm - #1 Trademark Filing since 2010.

2. Describe how your business or product is being used. Register your mark in 180+ countries.

What you get

1. Top Global Specialist - Credibility and Experience!

2. All processes will be performed in a timely manner. You will be informed periodically about the process.

What our customers say:

I wasn't too sure what to expect when taking up services, but the professionalism from the site to the customer service is the slickest I have ever experienced.

Camryn, Surrey, UK

How it works

1. Trademarkia Network Law firm - #1 Trademark Filing since 2010.

2. Describe how your business or product is being used. Register your mark in 180+ countries.

What you get

1. Top Global Specialist - Credibility and Experience!

2. All processes will be performed in a timely manner. You will be informed periodically about the process.

What our customers say:

I wasn't too sure what to expect when taking up services, but the professionalism from the site to the customer service is the slickest I have ever experienced.

Camryn, Surrey, UK

What You Can Do:

Start Your Business

Get FREE email alerts

Add to Favorites

Start Canada Trademark Filing

Custom Logo Design $99

Search on popular social networks

This mark may be available for re-registration. You can apply for it through Trademarkia at a low cost of $449!

Trademarkia.com will perform a final search in order to verify that this mark is available for Canada Trademark re-registration. All Trademarkia services are backed by a 100% satisfaction guarantee.

Trademarkia lets you see how your personal name, product name, trademark name or username is being used on any of 530+ new and popular social networks. Be the first to reserve your name and get help stopping others from using it - all in one place!

As seen on